Chemotherapy in the treatment of malignant brain tumors.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D001812:Blood-Brain Barrier; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004195:Disease Models, Animal; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D008926:Plicamycin / Q000627:therapeutic use; D011034:Podophyllotoxin / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D009607:Nitrosourea Compounds; D011344:Procarbazine; D014750:Vincristine; D003520:Cyclophosphamide; D011034:Podophyllotoxin; D008926:Plicamycin; D005472:Fluorouracil; D008727:Methotrexate